Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Sales | 1,337 | 1,250 | 1,360 | 1,482 | 1,458 |
| Gross Profit | 1,337 | 1,250 | 1,360 | 1,482 | 1,458 |
| Operating Expenses | 3,174 | 3,901 | 2,671 | 3,820 | 3,416 |
| Operating Income | -1,837 | -2,651 | -1,311 | -2,338 | -1,958 |
| Other Income | 73 | 87 | 61 | -54 | 71 |
| Pre-tax Income | -1,764 | -2,564 | -1,250 | -2,392 | -1,887 |
| Net Income Continuous | -1,764 | -2,564 | -1,250 | -2,392 | -1,887 |
| Net Income Discontinuous | 20 | -44 | -6 | N/A | -34 |
| Net Income | $-1,744 | $-2,608 | $-1,256 | $-2,257 | $-1,921 |
| EPS Basic Total Ops | -5.60 | -8.00 | -4.00 | -5.60 | -6.40 |
| EPS Basic Continuous Ops | -5.60 | -8.00 | -4.00 | -7.20 | -6.40 |
| EPS Basic Discontinuous Ops | 0.06 | -0.14 | -0.02 | N/A | -0.11 |
| EPS Diluted Total Ops | -5.60 | -8.00 | -4.00 | -5.60 | -6.40 |
| EPS Diluted Continuous Ops | -5.60 | -8.00 | -4.00 | -7.20 | -6.40 |
| EPS Diluted Discontinuous Ops | 0.06 | -0.14 | -0.02 | N/A | -0.11 |
| EBITDA(a) | $-1,836 | $-2,528 | $-1,202 | $-1,926 | $-1,884 |